Legend Biotech is a biotechnology company that focuses on the development and commercialization of innovative cell therapies for cancer treatment and other serious conditions. The company is particularly known for its work in chimeric antigen receptor (CAR) T-cell therapies, a groundbreaking approach that genetically modifies a patient’s own T-cells to better recognize and attack cancer cells. Legend Biotech aims to leverage advanced technology and cutting-edge research to address unmet medical needs in oncology and improve patient outcomes.
Stock News and Performance In a surprising turn of events, **Legend Biotech Corp** (LEGN) has seen its stock tumble by **5.01%**, settling at **$33.36** per share. The trading session recorded…